Orchestra BioMed Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	264	152	326	112	206	262
Market Cap Growth	19.03%	-53.41%	191.65%	-45.72%	-21.31%	-
Enterprise Value	184	87	229	193	-	-
Last Close Price	4.68	4.00	9.13	9.98	10.08	12.81
PS Ratio	69.37	57.64	118.24	31.67	-263.60	45.94
PB Ratio	6.04	4.61	4.80	2.13	-10.42	90.02
P/TBV Ratio	6.04	4.61	4.80	2.13	-	-
EV/Sales Ratio	65.46	32.97	82.96	54.51	-	-
Debt / Equity Ratio	0.37	0.50	0.03	0.23	-0.29	3.25
Asset Turnover	0.03	0.03	0.03	0.07	-	-
Inventory Turnover	0.66	1.28	0.88	1.23	2.91	-
Quick Ratio	4.64	4.13	7.82	4.52	0.90	2.50
Current Ratio	4.73	4.27	7.95	4.56	0.93	2.52
Return on Equity (ROE)	-166.97%	-120.84%	-81.47%	-205.22%	-	-
Return on Assets (ROA)	-52.21%	-46.90%	-33.75%	-37.42%	-52.79%	-
Return on Capital (ROIC)	-87.22%	-67.42%	-48.00%	-81.16%	-	-
Return on Capital Employed (ROCE)	-89.40%	-107.20%	-61.30%	-42.40%	-1693.80%	-79.00%
Earnings Yield	-28.42%	-40.13%	-15.05%	-30.04%	-11.16%	-8.15%
FCF Yield	-23.01%	-33.44%	-14.16%	-26.70%	-9.56%	-10.20%
Buyback Yield / Dilution	-15.74%	-10.82%	-121.67%	-609.97%	-4.86%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q